Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01082614 · ClinicalTrials.gov registry record · NA

Arterial Pulse Waveform Contour Analysis for Intraoperative Goal Directed Therapy in Major Abdominal Surgery

A NA study, sponsored by Loma Linda University.

Completed
Registry status
NA
Development phase
46
Enrollment target

NCT01082614: Completed NA study, sponsored by Loma Linda University.

NCT01082614 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01082614, a NA study, has completed, sponsored by Loma Linda University.

COMPLETED
Registry status
NA
Development phase
46 participants
Enrollment target

Study Summary

This study evaluates whether using information from a special arterial blood pressure monitor to guide how much fluid is given during surgery changes how long a patient stays in the hospital after the surgery. There is scientific evidence from using similar information from different devices that this technique might allow us to do a better job giving fluids during surgery and that this may be associated with shorter hospital stay after surgery.

Primary Outcome

time in days from end of surgery to hospital discharge

Interventions

  • DEVICE Vigileo

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2009-08
Est. Completion 2013-09
Phase NA
Loma Linda University

237 total trials

What the finished NCT01082614 record still lists

NCT01082614 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Vigileo is the first listed.

NCT01082614 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01082614 about?

NCT01082614 is a clinical study titled "Arterial Pulse Waveform Contour Analysis for Intraoperative Goal Directed Therapy in Major Abdominal Surgery". This study evaluates whether using information from a special arterial blood pressure monitor to guide how much fluid is given during surgery changes how long a patient stays in the hospital after the surgery. There is scientific evidence from using similar information from different devices that th...

What is the current status of trial NCT01082614?

This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2009-08. Estimated completion is 2013-09.

What interventions are being tested in trial NCT01082614?

The interventions under investigation include: Vigileo (DEVICE).

Who is sponsoring clinical trial NCT01082614?

This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01082614's enrollment target sits among peer trials

46 1402nd of 2000 higher than 590 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01890590 · 46 participants · NA

    A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

  • NCT03191149 · 46 participants · Phase 2

    Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • NCT03510208 · 46 participants · Phase 1

    Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • NCT04048278 · 46 participants · Early Phase 1

    Lidocaine Infusion in Pancreatic Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01082614, the US trial registry maintained by the National Library of Medicine. NCT01082614 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.